Funder
Chemical Industries Education and Training Authority (CHIETA), South Africa
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference10 articles.
1. Williams J, Taylor E. The evolution of hyperactivity, impulsivity and cognitive diversity. J R Soc Interface. 2006;3:399–413.
2. Ponizovsky MA, Marom E, Fitoussi I. Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005–2012. Pharmacoepidemiol Drug Saf. 2014;23:534–8.
3. Pottegard A, Bjerregaard BK, Glintborg D, Hallas J, Moreno SI. The use of medication against attention deficit hyperactivity disorder in Denmark: a drug study from a national perspective. Eur J Clin Pharmacol. 2012;68:1443–50.
4. Geirs PG, Pottegard A, Halldorsson M, Zoega H. A nationwide study of Attention-Deficit/Hyperactivity Disorder drug use among adults in Iceland 2003–2012. Basic Clin Pharmacol Toxicol. 2014;115(5):417–22.
5. WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs, 2017. Oslo, Norway 2016.
https://www.whocc.no/atc_ddd_index/
. Accessed 09 Dec 2017.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献